Find your next paid study

Vedanta Biosciences, Inc.NCT06237452

~$10 – $8,750

Phase 2

A Phase IIb, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of AZD5148 for Prevention of Recurrence of Clostridioides Difficile Infection in Individuals 18 Years of Age and Above

The purpose of this study is to evaluate the efficacy and safety of AZD5148 for prevention of recurrence of Clostridioides difficile infection in Individuals 1…

Clostridioides Difficile Infection

~$10 – $7,500

AstraZenecaNCT07285213

Recurrent Clostridioides Difficile InfectionColonic Surgery

An Open-Label, Pilot Clinical Trial To Test The Safety And Feasibility Of Intestinal Microbiota Transplantation In Patients Undergoing Colon Resection

This is a single-center, open-label study for safety and feasibility of IMT in patients undergoing colonic surgery. After consent, individuals of the ages of 1…

University of MinnesotaNCT06370884

Observational

Diet for Prevention of Recurrent C. Difficile Infection

This study aims to evaluate the impact of diet on the gut microbiome in adults with Clostridioides difficile infection (CDI). Eligible participants will be ran…

Clostridioides Difficile Infection

University of MichiganNCT07613645

Recurrent Clostridioides Difficile InfectionColonic Surgery

An Open-Label, Pilot Clinical Trial To Test The Safety And Feasibility Of A Suspension of Freeze-dried Microbiota In Patients Undergoing Colon Resection

This Phase 1 pilot clinical trial that will evaluate the initial safety and feasibility of orally administered preparation of fecal microbiota (MTP-101P) in pa…

University of MinnesotaNCT06692179

A Prospective, Observational Study to Evaluate C. Difficile Toxin Levels in Stool in Healthy Individuals Following Standard of Care Antibiotic Treatment for CDI.

Hospitals and clinics interested in participating in this multi-site study, please contact the people mentioned under "Contacts and Locations". The goal of th…

Clostridioides Difficile Infection Recurrence

Clostridioides Difficile InfectionClostridium Difficile InfectionClostridium Difficile Diarrhea+1 more

~$10 – $1,125

Bactolife A/SNCT07250724

Phase 2

Alanyl-glutamine Supplementation of Standard Treatment for C. Difficile Infection: a Randomized, Double-blind, Placebo-controlled Trial

This is a randomized, double-blind, placebo-controlled trial to determine the optimal dose and safety of oral alanyl-glutamine between 4, 24, and 44 g doses ad…

University of VirginiaNCT04305769

Phase 4

Use of Fidaxomicin Compared to Vancomycin for Decolonization of C. Difficile in Patients With Inflammatory Bowel Disease

This is a randomized, double-blind study to assess the safety and efficacy of fidaxomicin compared to vancomycin for decolonization of C. difficile in IBD pati…

Inflammatory Bowel Disease (IBD)Clostridioides Difficile Infection

Brigham and Women's HospitalNCT06794944

Inflammatory Bowel Disease (IBD)Clostridioides Difficile Infection

Pilot Trial of Xylitol for C. Difficile De-Colonization in Patients With Inflammatory Bowel Disease

This 3+3 dose escalation pilot trial will assess the safety and efficacy of xylitol as an oral therapeutic for decolonization of C. difficile in the Inflammato…

Brigham and Women's HospitalNCT06799039

Clostridioides Difficile Infection

PREVENTION OF RECURRENCE OF CLOSTRIDIOIDES DIFFICILE COLITIS WITH URSODEOXYCHOLIC ACID (UCDA) AS A SUPPLEMENT TO STANDARD THERAPY

The goal of this clinical trial is to determine whether Ursodeoxycholic Acid (UDCA) can help prevent recurrence of Clostridioides difficile (C. diff) colitis w…

Medical College of WisconsinNCT06884748

Inflammatory Bowel DiseasesClostridioides Difficile Infection

Xylitol Use for Decolonization of C. Difficile in Patients With Inflammatory Bowel Disease

This is a randomized, placebo-controlled, dose-ranging study to assess the safety and efficacy of xylitol as an oral therapeutic for decolonization of C. diffi…